OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fragment-based drug design targeting syntenin PDZ2 domain involved in exosomal release and tumour spread
Manon Garcia, Laurent Hoffer, Raphaël Leblanc, et al.
European Journal of Medicinal Chemistry (2021) Vol. 223, pp. 113601-113601
Open Access | Times Cited: 10

Showing 10 citing articles:

Insights into tumor-derived exosome inhibition in cancer therapy
Ziwei Tang, Cheng Chen, Chen Zhou, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117278-117278
Closed Access | Times Cited: 3

Extracellular vesicles in tumor immunity: mechanisms and novel insights
Liwen Kuang, Lei Wu, Yongsheng Li
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 3

MDA-9/Syntenin as a therapeutic cancer metastasis target: current molecular and preclinical understanding
Swadesh K. Das, Paul B. Fisher
Expert Opinion on Therapeutic Targets (2025)
Closed Access

Bibliometrics Analysis and Knowledge Mapping of Fragment-Based Drug Design Research: Trends from 2015 to 2024
Chenming He, J.S. Zhang, Runze Zhang, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 4245-4262
Open Access

Biological Role and Aberrant Overexpression of Syntenin-1 in Cancer: Potential Role as a Biomarker and Therapeutic Target
Valeria Guadalupe Pintor-Romero, Edgar Hurtado-Ortega, María Lilia Nicolás-Morales, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1034-1034
Open Access | Times Cited: 7

Design and Synthesis of Small Molecule Probes of MDA-9/Syntenin
Nehru Viji Sankaranarayanan, Bharath Kumar Villuri, Balaji Nagarajan, et al.
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1287-1287
Open Access | Times Cited: 2

Revisiting the Syndecans: Master Signaling Regulators with Prognostic and Targetable Therapeutic Values in Breast Carcinoma
Juliana María Motta, Hebatallah Hassan, Sherif Ibrahim
Cancers (2023) Vol. 15, Iss. 6, pp. 1794-1794
Open Access | Times Cited: 6

Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis
Anjan K. Pradhan, Jinkal Modi, Santanu Maji, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 10, pp. 1115-1127
Closed Access | Times Cited: 3

Discovery of a potent inhibitor that suppresses glioblastoma by dual targeting of both syntenin PDZ domains
Yunseok Heo, Jihoon Moon, Jisoo Lee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

ChemoDOTS: a web server to design chemistry-driven focused libraries
Laurent Hoffer, Guillaume Charifi-Hoareau, Sarah Barelier, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. W1, pp. W461-W468
Open Access

Page 1

Scroll to top